Alfa Digital Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Software
Main Product/Service
Future PharmaTech uses its proprietary “Future‑AI platform,” integrating drug repurposing and mechanism simulation to develop novel compounds capable of penetrating the blood‑brain barrier (BBB), targeting conditions such as vascular dementia (VD) and ere
The content above was translated by Ai
Founded Year
2023
Unified Business No.
94004036
Status
Active
Number of Employees
0
Total Paid-in
Capital
8,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Future PharmaTech, founded in 2021, focuses on neurological and vascular disorders, leveraging its proprietary AI‑driven drug discovery platform and nanomedicine technologies to rapidly develop effective, safe and precision therapies designed to improve p
The content above was translated by Ai
